MEDIFAST, INC.

MED
Delayed Quote. Delayed  - 01/22 04:10:00 pm
220.87USD -0.20%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 714917
EBITDA1 95,7146
Operating profit (EBIT)1 91,0139
Operating Margin 12,8%15,2%
Pre-Tax Profit (EBT)1 92,4133
Net income1 77,9103
Net margin 10,9%11,2%
EPS2 6,438,69
Dividend per Share2 -4,52
Last update 02/26/202011/03/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt1 --
Net Cash position1 92,7165
Leverage (Debt / EBITDA) -0,97x-1,13x
Free Cash Flow1 74,2126
ROE (Net Profit / Equities) 72,8%82,7%
Shareholders' equity1 107125
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share --
Cash Flow per Share --
Capex1 10,18,00
Capex / Sales 1,41%0,87%
Last update 02/26/202001/25/2021
1 USD in Million
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 2 588 M $ -
Entreprise Value (EV) 2 423 M $ 2 374 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 25,4x 20,6x
Capitalization / Revenue 2,82x 2,40x
EV / Revenue 2,64x 2,24x
EV / EBITDA 16,6x 14,0x
Yield (DPS / Price) 2,05% 2,05%
Price to book (Price / BVPS) - -
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 15,2% 15,2%
Operating Leverage (Delta EBIT / Delta Sales) 1,86x 1,00x
Net Margin (Net Profit / Revenue) 11,2% 11,8%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 82,7% 68,1%
Rate of Dividend 52,0% 42,3%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   0,87% 1,65%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend